Literature DB >> 15980061

Trends in mortality after hospital admission for liver cirrhosis in an English population from 1968 to 1999.

S E Roberts1, M J Goldacre, D Yeates.   

Abstract

BACKGROUND: Population based mortality rates from liver cirrhosis, and alcohol consumption, have increased sharply in Britain in the past 35 years. Little is known about the long term trends over time in mortality rates after hospital admission for liver cirrhosis. AIMS: To analyse time trends in mortality in the year after admission for liver cirrhosis from 1968 to 1999.
SUBJECTS: A total of 8192 people who were admitted to hospital in a defined population of Southern England.
METHODS: Analysis of hospital discharge statistics linked to death certificate data. The main outcome measures were case fatality rates (CFRs) and standardised mortality ratios (SMRs).
RESULTS: At 30 days after admission, CFR was 15.9% and the SMR was 93 (86 in men and 102 in women, compared with 1 in the general population). At one year, the overall CFR was 33.6% and SMR was 16.3. There was no improvement from 1968 to 1999 in mortality rates. SMRs were highest for alcoholic cirrhosis of the liver (27.4 at one year) but lower for biliary cirrhosis (11.4) and chronic hepatitis (10.0). Mortality from most of the main causes of death, including accidents and suicides, was increased.
CONCLUSIONS: The high mortality rates after hospital admission, and the fact that they have not fallen in the past 30 years, show that liver cirrhosis remains a disease with a very poor prognosis. Increased mortality from accidents, suicides, and mental disorders, particularly among those with alcoholic cirrhoses, indicates that prognosis is influenced by behavioural as well as by physical pathology.

Entities:  

Mesh:

Year:  2005        PMID: 15980061      PMCID: PMC1774743          DOI: 10.1136/gut.2004.058636

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Rates of liver cirrhosis rise in England, fall in Europe.

Authors:  A Vass
Journal:  BMJ       Date:  2001-12-15

2.  Reductions in liver cirrhosis mortality and morbidity in Canada: demographic differences and possible explanations.

Authors:  R E Mann; R G Smart; L Anglin
Journal:  Alcohol Clin Exp Res       Date:  1988-04       Impact factor: 3.455

3.  Changing trends of cirrhosis mortality in Ontario, Canada, 1911-1986.

Authors:  M L Halliday; R A Coates; J G Rankin
Journal:  Int J Epidemiol       Date:  1991-03       Impact factor: 7.196

4.  Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark.

Authors:  Henrik Toft Sørensen; Ane Marie Thulstrup; Lene Mellemkjar; Peter Jepsen; Erik Christensen; Jørgen H Olsen; Hendrik Vilstrup
Journal:  J Clin Epidemiol       Date:  2003-01       Impact factor: 6.437

5.  Main causes of death in cirrhosis.

Authors:  P Schlichting; E Christensen; L Fauerholdt; H Poulsen; E Juhl; N Tygstrup
Journal:  Scand J Gastroenterol       Date:  1983-10       Impact factor: 2.423

6.  Delayed increases in liver cirrhosis mortality and frequency of alcoholic liver cirrhosis following an increment and redistribution of alcohol consumption in Finland: evidence from mortality statistics and autopsy survey covering 8533 cases in 1968-1988.

Authors:  V T Savolainen; A Penttilä; P J Karhunen
Journal:  Alcohol Clin Exp Res       Date:  1992-08       Impact factor: 3.455

7.  National statistics for diet, alcohol consumption, and chronic pancreatitis in England and Wales, 1960-88.

Authors:  C D Johnson; S Hosking
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

8.  Effect of alcoholism treatment on cirrhosis mortality: a 20-year multivariate time series analysis.

Authors:  H D Holder; R N Parker
Journal:  Br J Addict       Date:  1992-09

9.  Trends in alcohol-related morbidity and mortality.

Authors:  G D Williams; B F Grant; F S Stinson; T S Zobeck; S S Aitken; J Noble
Journal:  Public Health Rep       Date:  1988 Nov-Dec       Impact factor: 2.792

10.  A prospective study of alcoholic liver disease and mortality.

Authors:  I A Bouchier; W S Hislop; R J Prescott
Journal:  J Hepatol       Date:  1992-11       Impact factor: 25.083

View more
  25 in total

1.  A pharmacodynamic model of portal hypertension in isolated perfused rat liver.

Authors:  Tao Zhang; Xue-Yan Xu; Hang Zhou; Xin Zhao; Meng Song; Tao-Tao Zhang; He Yin; Ting Li; Peng-Tao Li; Da-Yong Cai
Journal:  World J Gastroenterol       Date:  2012-02-07       Impact factor: 5.742

2.  Prenatal dexamethasone exposure potentiates diet-induced hepatosteatosis and decreases plasma IGF-I in a sex-specific fashion.

Authors:  David L Carbone; Damian G Zuloaga; Ryoko Hiroi; Chad D Foradori; Marie E Legare; Robert J Handa
Journal:  Endocrinology       Date:  2011-11-08       Impact factor: 4.736

Review 3.  Mortality from cirrhosis: lack of progress over the last 35 years.

Authors:  C Gluud
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

Review 4.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

5.  Incidence and Outcomes for Patients With Cirrhosis Admitted to the United Kingdom Critical Care Units.

Authors:  Mark J W McPhail; Francesca Parrott; Julia A Wendon; David A Harrison; Kathy A Rowan; William Bernal
Journal:  Crit Care Med       Date:  2018-05       Impact factor: 7.598

6.  Risk Trajectories for Readmission and Death After Cirrhosis-Related Hospitalization.

Authors:  Aylin Tansel; Jennifer Kramer; Hua Feng; Hashem B El-Serag; Fasiha Kanwal
Journal:  Dig Dis Sci       Date:  2019-01-23       Impact factor: 3.199

7.  IκB kinase-beta inhibitor attenuates hepatic fibrosis in mice.

Authors:  Jue Wei; Min Shi; Wei-Qi Wu; Hui Xu; Ting Wang; Na Wang; Jia-Li Ma; Yu-Gang Wang
Journal:  World J Gastroenterol       Date:  2011-12-21       Impact factor: 5.742

8.  Increased Risk of Death, in the Hospital and Outside the Intensive Care Unit, for Patients With Cirrhosis After Cardiac Arrest.

Authors:  Megan E Reinders; Gabriel Wardi; Ricki Bettencourt; Daniel Bouland; Jessica Bazick; Michel Mendler; Irine Vodkin; Denise Kalmaz; Thomas Savides; David Brenner; Rebecca E Sell; Rohit Loomba
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-07       Impact factor: 11.382

9.  Developing a 'traffic light' test with potential for rational early diagnosis of liver fibrosis and cirrhosis in the community.

Authors:  Nick Sheron; Mike Moore; Stacey Ansett; Camille Parsons; Adrian Bateman
Journal:  Br J Gen Pract       Date:  2012-09       Impact factor: 5.386

10.  Decreasing Mortality Among Danish Alcoholic Cirrhosis Patients: A Nationwide Cohort Study.

Authors:  Thomas Deleuran; Hendrik Vilstrup; Peter Jepsen
Journal:  Am J Gastroenterol       Date:  2016-04-05       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.